Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus
Yaling Wang,Yuping Xie,Jia Luo,Mengyu Guo,Xuhao Hu,Xi Chen,Ziwei Chen,Xinyi Lu,Lichun Mao,Kai Zhang,Liangnian Wei,Yunfei Ma,Ruixin Wang,Jia Zhou,Chunyan He,Yufang Zhang,Ye Zhang,Sisi Chen,Lijuan Shen,Yun Chen,Nasha Qiu,Ying Liu,Yanyan Cui,Guoyang Liao,Ye Liu,Chunying Chen
DOI: https://doi.org/10.1016/j.nantod.2021.101139
IF: 17.4
2021-06-01
Nano Today
Abstract:<p>Effective vaccines are vital to the fight against the COVID-19 global pandemic. As a critical component of a subunit vaccine, the adjuvant is responsible for strengthening the antigen-induced immune responses. Here, we present a new nanovaccine that comprising the Receptor-Binding Domain (RBD) of spike protein and the manganese nanoadjuvant (MnARK), which induces humoral and cellular responses. Notably, even at a 5-fold lower antigen dose and with fewer injections, mice immunized with the MnARK vaccine immunized mice showed stronger neutralizing abilities against the infection of the pseudovirus (~270-fold) and live coronavirus (>8-fold) <em>in vitro</em> than that of Alum-adsorbed RBD vaccine (Alu-RBD). Furthermore, we found that the effective co-delivery of RBD antigen and MnARK to lymph nodes (LNs) elicited an increased cellular internalization and the activation of immune cells, including DC cells, CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes. Our findings highlight the importance of MnARK adjuvant in the design of novel coronavirus vaccines and provide a rationale strategy to design protective vaccines through promoting cellular internalization and the activation of immune-related pathways.</p>
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry